Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation

Annelies C. Wauters, Jari F. Scheerstra, Irma G. Vermeijlen, Roel Hammink, Marjolein Schluck, Laura Woythe, Hanglong Wu, Lorenzo Albertazzi, Carl G. Figdor, Jurjen Tel, Loai K.E.A. Abdelmohsen (Corresponding author), Jan C.M. van Hest (Corresponding author)

Onderzoeksoutput: Bijdrage aan tijdschriftTijdschriftartikelAcademicpeer review

49 Citaten (Scopus)
94 Downloads (Pure)

Samenvatting

Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to activate T cells ex or in vivo, offer an effective alternative to cellular immunotherapies. However, comprehensive studies that delineate the effect of nano-aAPC topology, including nanoparticle morphology and ligand density, are lacking. Here, we systematically studied the topological effects of polymersome-based aAPCs on T cell activation. We employed an aAPC library created from biodegradable poly(ethylene glycol)-block-poly(d,l-lactide) (PEG-PDLLA) polymersomes with spherical or tubular shape and variable sizes, which were functionalized with αCD3 and αCD28 antibodies at controlled densities. Our results indicate that high ligand density leads to enhancement in T cell activation, which can be further augmented by employing polymersomes with larger size. At low ligand density, the effect of both polymersome shape and size was more pronounced, showing that large elongated polymersomes better activate T cells compared to their spherical or smaller counterparts. This study demonstrates the capacity of polymersomes as aAPCs and highlights the role of topology for their rational design.

Originele taal-2Engels
Pagina's (van-tot)15072–15085
Aantal pagina's14
TijdschriftACS Nano
Volume16
Nummer van het tijdschrift9
Vroegere onlinedatum15 aug. 2022
DOI's
StatusGepubliceerd - 27 sep. 2022

Bibliografische nota

Publisher Copyright:
©

Financiering

A.C.W., L.K.E.A.A., and J.C.M.v.H. acknowledge support from the Dutch Ministry of Education, Culture and Science (Gravitation Program 024.001.035), the Spinoza premium, and the ERC Advanced Grant (Artisym 694120). J.T. is supported by an ERC Starting Grant (ImmunoCode 802791).

FinanciersFinanciernummer
European Union’s Horizon Europe research and innovation programme802791, 694120
European Research Council
Ministerie van OCW024.001.035

    Vingerafdruk

    Duik in de onderzoeksthema's van 'Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation'. Samen vormen ze een unieke vingerafdruk.

    Citeer dit